Nabulsi Azmi's most recent trade in Phathom Pharmaceuticals Inc was a trade of 79,200 Common Stock done . Disclosure was reported to the exchange on Feb. 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 79,200 | 312,590 (1%) | 0% | 0 | Common Stock | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.59 per share. | 21 Jan 2025 | 7,886 | 233,390 (0%) | 0% | 6.6 | 51,957 | Common Stock |
| Phathom Pharmaceuticals Inc | Nabulsi Azmi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 19 Dec 2024 | 1,118 | 239,303 (0%) | 0% | 8 | 8,944 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 11.72 per share. | 15 Jul 2024 | 10,901 | 240,421 (0%) | 0% | 11.7 | 127,760 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 7,500 | 249,567 (1%) | 0% | 0 | Common Stoock | |
| Phathom Pharmaceuticals Inc | Nabulsi Azmi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 130,000 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jul 2023 | 150,000 | 0 | - | - | Stock Option | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 110,000 | 209,567 (0%) | 0% | - | Common Stock | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Jul 2023 | 70,000 | 0 | - | - | Stock Option | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 8.26 per share. | 11 Apr 2023 | 10,000 | 99,567 (0%) | 0% | 8.3 | 82,600 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2023 | 45,000 | 89,567 (0%) | 0% | 0 | Common Stock | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 7,500 | 41,971 (0%) | 0% | 0 | Common Stock | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 12,000 | 33,378 (0%) | 0% | 0 | Common Stock | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 8.16 per share. | 16 May 2022 | 20,000 | 785,700 (3%) | 0% | 8.2 | 163,288 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 38.59 per share. | 03 May 2021 | 5,753 | 770,157 (3%) | 0% | 38.6 | 221,994 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 37.85 per share. | 03 May 2021 | 4,290 | 775,910 (3%) | 0% | 37.8 | 162,360 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 36.15 per share. | 03 May 2021 | 1,968 | 768,189 (3%) | 0% | 36.2 | 71,150 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 37.09 per share. | 03 May 2021 | 1,400 | 766,789 (3%) | 0% | 37.1 | 51,921 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 37.86 per share. | 03 May 2021 | 1,089 | 765,700 (3%) | 0% | 37.9 | 41,231 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 36.37 per share. | 01 Apr 2021 | 4,316 | 780,985 (3%) | 0% | 36.4 | 156,954 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.66 per share. | 01 Apr 2021 | 4,252 | 785,301 (3%) | 0% | 35.7 | 151,645 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 37.28 per share. | 01 Apr 2021 | 3,405 | 791,295 (3%) | 0% | 37.3 | 126,927 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 38.14 per share. | 01 Apr 2021 | 1,742 | 789,553 (3%) | 0% | 38.1 | 66,442 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 37.11 per share. | 01 Apr 2021 | 785 | 780,200 (3%) | 0% | 37.1 | 29,134 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.16 per share. | 01 Mar 2021 | 4,833 | 798,394 (3%) | 0% | 46.2 | 223,080 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.77 per share. | 01 Mar 2021 | 3,825 | 805,375 (3%) | 0% | 45.8 | 175,069 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.23 per share. | 01 Mar 2021 | 2,070 | 794,700 (3%) | 0% | 46.2 | 95,695 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.17 per share. | 01 Mar 2021 | 1,600 | 796,770 (3%) | 0% | 45.2 | 72,276 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.05 per share. | 01 Mar 2021 | 1,548 | 803,827 (3%) | 0% | 46.1 | 71,293 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 44.60 per share. | 01 Mar 2021 | 600 | 803,227 (3%) | 0% | 44.6 | 26,757 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.75 per share. | 01 Mar 2021 | 24 | 798,370 (3%) | 0% | 46.8 | 1,122 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 41.16 per share. | 01 Feb 2021 | 6,384 | 809,200 (3%) | 0% | 41.2 | 262,782 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 38.09 per share. | 01 Feb 2021 | 5,416 | 818,284 (3%) | 0% | 38.1 | 206,285 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 40.51 per share. | 01 Feb 2021 | 2,700 | 815,584 (3%) | 0% | 40.5 | 109,373 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.93 per share. | 04 Jan 2021 | 7,614 | 825,654 (3%) | 0% | 33.9 | 258,367 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.02 per share. | 04 Jan 2021 | 4,932 | 833,268 (3%) | 0% | 33.0 | 162,842 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.77 per share. | 04 Jan 2021 | 1,854 | 823,700 (3%) | 0% | 33.8 | 62,608 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.57 per share. | 04 Jan 2021 | 100 | 825,554 (3%) | 0% | 34.6 | 3,457 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 43.99 per share. | 01 Dec 2020 | 5,370 | 847,330 (3%) | 0% | 44.0 | 236,226 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.05 per share. | 01 Dec 2020 | 4,307 | 841,195 (3%) | 0% | 45.0 | 194,030 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.57 per share. | 01 Dec 2020 | 2,995 | 838,200 (3%) | 0% | 45.6 | 136,482 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 44.83 per share. | 01 Dec 2020 | 1,828 | 845,502 (3%) | 0% | 44.8 | 81,949 | Common Stock |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Nov 2020 | 867,200 | 867,200 (3%) | 3% | 0 | Common Stock | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Nov 2020 | 867,200 | 0 (0%) | 3% | 0 | Common Stock | |
| Phathom Pharmaceuticals Inc | Azmi Nabulsi | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 36.83 per share. | 02 Nov 2020 | 14,500 | 852,700 (3%) | 0% | 36.8 | 534,026 | Common Stock |